SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000898432-09-000054
Filing Date
2009-01-21
Accepted
2009-01-21 16:19:03
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 avalonsc13ga.htm SC 13G/A 264909
  Complete submission text file 0000898432-09-000054.txt   267051
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 20358 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20358 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 3015569900
AVALON PHARMACEUTICALS INC (Subject) CIK: 0001162192 (see all company filings)

IRS No.: 522209310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81073 | Film No.: 09536859
SIC: 2834 Pharmaceutical Preparations